4 ms·
If it was up to the US, maybe things would be that slow, but I think you are not properly appreciating how fast CRISPR is advancing. The CEO of BioViva has alre
by gwern 11y ago
If it was up to the US, maybe things would be that slow, but I think you are not properly appreciating how fast CRISPR is advancing. The CEO of BioViva has already injected herself with edits relating to telomeres, and it's about ready for embryo editing: the main barrier was off-target mutations (this was the problem with the Chinese embryo editing last year), and that has effectively been solved with some tweaks to the enzyme to yield ~0% off-target mutations. As stem cell treatments show, the bioconservatives in the USA can try to slow things down, but the USA is not the only place in the world with biomedical expertise these days.